Tri-Buffered Aspirin Prices, Coupons and Patient Assistance Programs
Tri-Buffered Aspirin (aspirin) is a member of the platelet aggregation inhibitors drug class and is commonly used for Angina, Angina Pectoris Prophylaxis, Ankylosing Spondylitis, and others.
Tri-Buffered Aspirin Prices
This Tri-Buffered Aspirin price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Tri-Buffered Aspirin oral tablet buffered 325 mg is around $12 for a supply of 100 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Tri-Buffered Aspirin Coupons and Rebates
Tri-Buffered Aspirin offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Patient Assistance Programs for Tri-Buffered Aspirin
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
More about Tri-Buffered Aspirin (aspirin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Drug class: platelet aggregation inhibitors
- FDA Alerts (2)